Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4120 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL448978 | 1.00 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL11171710 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL10534641 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL57771 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL23830054 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL3251868 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3765047 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL9139618 | 0.94 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3250336 | 0.94 | ALDH1A1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114748361-B | Fiber net reinforced pre-crown with function of preventing caries | 北京大学口腔医学院 | 2022-09-06 | — | — | CN | claimed |
| CN-114748361-A | Fiber net reinforced pre-crown with function of preventing caries | 北京大学口腔医学院 | 2022-07-15 | — | — | CN | claimed |
| CN-114533688-A | Granular preparation of 5-methyl-1-phenyl-2- (1H) -pyridone and preparation method thereof | 霍夫曼-拉罗奇有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-109564286-A | Detector at least one object of optical detection | 特里纳米克斯股份有限公司 | 2019-04-02 | — | — | CN | claimed |
| CN-207964073-U | A kind of low-grade fever formula sound transducer | 北京北方高业科技有限公司 | 2018-10-12 | — | — | CN | claimed |
| CN-108180984-A | A kind of low-grade fever formula sound transducer and preparation method thereof | 北京北方高业科技有限公司 | 2018-06-19 | — | — | CN | claimed |
| WO-2014132226-A1 | STABLE DISPERSIBLE FORMULATION OF ARTEROLANE MALEATE AND PIPERAQUINE AND PROCESS OF PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2014-09-04 | — | — | WO | claimed |
| CN-224271143-U | Production device of potassium dihydrogen phosphate | ZHUCHENG HAOTIAN PHARM CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260108622-A1 | NON-PEGYLATED LIPID NANOPARTICLES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4727530-A2 | ION CHANNEL BINDERS AND USES THEREOF | President and Fellows of Harvard College (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4685123-A2 | USE OF MODIFIED GEOPOLYMER FOR DECREASING THE THERMAL CONDUCTIVITY OF VINYL AROMATIC POLYMERS | Synthos Dwory 7 spolka z ograniczona odpowiedzialnoscia (PL) | 2026-01-28 | — | — | EP | disclosed |
| US-20250375441-A1 | ONCOLYTIC THERAPY WITH A DUAL HDAC3 AND HDAC8 TARGETING AGENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-12-11 | — | — | US | disclosed |
| WO-2025226829-A1 | DENDRIMER FORMULATIONS AND USES THEREOF | Ashvattha Therapeutics, Inc. (US) | 2025-10-30 | — | — | WO | disclosed |
| WO-2005107773-A2 | SOLID DOSAGE FORM OF WETTED HEPARIN | EMISPHERE TECHNOLOGIES, INC. (US) | 2005-11-17 | — | — | WO | disclosed |
| WO-2005107462-A2 | CRYSTALLINE POLYMORPHIC FORMS OF MONOSODIUM N-[8-(2-HYDROXYBENZOYL)AMINO]CAPRYLATE | EMISPHERE TECHNOLOGIES, INC. (US) | 2005-11-17 | — | — | WO | disclosed |
| US-20050036977-A1 | Taste-masked resinate and preparation thereof | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-17 | — | — | US | disclosed |
| US-6326038-B1 | ORGANOLEPTICAL MIXTURE OF CALCIUM SULFATE AND TRICALCIUM PHOSPHATE WITH REDUCED BITTERNESS AND GRAININESS; HIGH LEVELS OF CALCIUM WITHOUT EXCESSIVE LEVELS OF CALCIUM COMPOUNDS | KRAFT FOODS, INC. | 2001-12-04 | — | — | US | disclosed |
| EP-1138207-A2 | Calcium fortification of cheese and yogurt | KRAFT FOODS, INC. (US) | 2001-10-04 | — | — | EP | disclosed |
| CN-1200714-A | Method and apparatus for producing cement clinker | JOSEPH E DOUMET (LB) | 1998-12-02 | — | — | CN | disclosed |
| US-5773031-A | POLYMERIC COATING OF A METHACRYLATE ESTER COPOLYMER; WATER INSOLUBLE BUT WATER PERMEABLE | L. PERRIGO COMPANY (US) | 1998-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108622-A1 | NON-PEGYLATED LIPID NANOPARTICLES | CD44, ASGR1, PLTP | MEN1 4395/4885ALDH1A1 2710/4885TSHR 931/4885 |
| US-20250375441-A1 | ONCOLYTIC THERAPY WITH A DUAL HDAC3 AND HDAC8 TARGETING AGENT | HDAC8, HDAC1, HDAC3 | MEN1 3537/4885ALDH1A1 3241/4885TSHR 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.